SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis

References

• Janjua N, Wreesmann VB. Aggressive differentiated thyroid cancer. Eur J Surg Oncol. 2018;44(3):367–377.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health. 2015;27(2):9–223 .
   Web of Science ®Google Scholar
• Carlberg M, Hedendahl L, Ahonen M, et al. Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data. BMC Cancer. 2016;16(1):426.
   PubMedGoogle Scholar
• Sharifi A, Shojaeifard A, Soroush A, et al. Predictors of regional lymph node recurrence after initial thyroidectomy in patients with thyroid cancer. J Thyroid Res. 2016;2016:4127278.
   PubMedGoogle Scholar
• Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184–199.
   PubMed Web of Science ®Google Scholar
• Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106(3):524–531.
   PubMed Web of Science ®Google Scholar
• Schmidbauer B, Menhart K, Hellwig D, et al. Differentiated thyroid cancer-treatment: state of the art. Int J Mol Sci. 2017;18(6):1292.
   PubMed Web of Science ®Google Scholar
• Naoum GE, Morkos M, Kim B, et al. Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol Cancer. 2018;17(1):51.
   PubMedGoogle Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Liu H, Deng H, Zhao Y, et al. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res. 2018;37(1):279.
   PubMedGoogle Scholar
• Liang M, Jia J, Chen L, et al. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Endocrine. 2019;65(2):318–326.
   PubMed Web of Science ®Google Scholar
• Li Y, Cao X, Li H. Identification and validation of novel long non-coding RNA biomarkers for early diagnosis of oral squamous cell carcinoma. Front Bioeng Biotechnol. 2020;8:256.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Colombrita C, Onesto E, Megiorni F, et al. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem. 2012;287(19):15635–15647.
   PubMed Web of Science ®Google Scholar
• Ishigaki S, Masuda A, Fujioka Y, et al. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep. 2012;2(1):529.
   PubMedGoogle Scholar
• Ge Z, Cheng Z, Yang X, et al. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma. Cancer Sci. 2017;108(4):653–662.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Z, Sheng F, et al. MYC upregulated LINC00319 promotes human acute myeloid leukemia (AML) cells growth through stabilizing SIRT6. Biochem Biophys Res Commun. 2019;509(1):314–321.
   PubMed Web of Science ®Google Scholar
• Jafar-Nejad H, Norga K, Bellen HN. “Adapting” notch for endocytosis. Dev Cell. 2002;3(2):155–156.
   PubMed Web of Science ®Google Scholar
• Flores AN, McDermott N, Meunier A, et al. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nat Rev Urol. 2014;11(9):499–507.
   PubMed Web of Science ®Google Scholar
• Cao X, Yao N, Zhao Z, et al. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway. Bioengineered. 2022;13(3):7771–7784.
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang H, Tang J, et al. Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma. Bioengineered. 2022;13(3):7919–7925.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yang L, Hou L, et al. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Bioengineered. 2021;12(2):9239–9250.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li X, Xu J, et al. Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway. Bioengineered. 2022;13(2):3526–3536.
   PubMed Web of Science ®Google Scholar
• Ding C, Shi T, Wu G, et al. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2. Bioengineered. 2022;13(3):6629–6640.
   PubMed Web of Science ®Google Scholar
• Huang C, Liu J, He L, et al. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development. Bioengineered. 2021;12(2):11738–11755.
   PubMed Web of Science ®Google Scholar
• Cai L, Hu X, Ye L, et al. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer. Bioengineered. 2022;13(4):8226–8239.
   PubMed Web of Science ®Google Scholar
• Qi F, Tang J, Cai Z, et al. Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway. Bioengineered. 2022;13(3):7592–7606.
   PubMed Web of Science ®Google Scholar
• Shi P, Liu Y, Yang D, et al. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered. 2022;13(2):4372–4384.
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–16.e11.
   PubMed Web of Science ®Google Scholar
• Therneau TM. Survival analysis [R package survival version 2.39-5]. Technometrics. 2015;46(1):111–112.
   Google Scholar
• Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783–2795.
   PubMed Web of Science ®Google Scholar
• Liu X, Fu Q, Li S, et al. LncRNA FOXD2-AS1 functions as a competing endogenous RNA to regulate TERT expression by sponging miR-7-5p in thyroid cancer. Front Endocrinol (Lausanne). 2019;10:207.
   PubMed Web of Science ®Google Scholar
• Credendino SC, Bellone ML, Lewin N, et al. A ceRNA circuitry involving the long noncoding RNA Klhl14-AS, Pax8, and Bcl2 drives thyroid carcinogenesis. Cancer Research. 2019;79(22):5746–5757.
   PubMed Web of Science ®Google Scholar
• Lv P, Xue Y. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway. Bioengineered. 2021;12(1):3873–3885.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang H, Wang H, et al. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4. Bioengineered. 2021;12(1):496–506.
   PubMed Web of Science ®Google Scholar
• Guo GL, Sun LQ, Sun MH, et al. LncRNA SLC8A1-AS1 protects against myocardial damage through activation of cGMP-PKG signaling pathway by inhibiting SLC8A1 in mice models of myocardial infarction. J Cell Physiol. 2019;234(6):9019–9032.
   PubMed Web of Science ®Google Scholar
• Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141(2):140–149.
   PubMed Web of Science ®Google Scholar
• Peng JH, Wang XL, Ran L, et al. Retracted: inhibition of Notch signaling pathway enhanced the radiosensitivity of breast cancer cells. J Cell Biochem. 2018;119(10):8398–8409.
   PubMed Web of Science ®Google Scholar
• Choi D, Ramu S, Park E, et al. Aberrant activation of notch signaling inhibits PROX1 activity to enhance the malignant behavior of thyroid cancer cells. Cancer Res. 2016;76(3):582–593.
   PubMed Web of Science ®Google Scholar
• Garcia-Heredia JM, Verdugo Sivianes EM, Lucena-Cacace A, et al. Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy. Oncotarget. 2016;7(39):63611–63628.
   PubMedGoogle Scholar
• Yan Y, Xu Z, Chen X, et al. Novel function of lncRNA ADAMTS9-AS2 in promoting temozolomide resistance in glioblastoma via upregulating the FUS/MDM2 ubiquitination axis. Front Cell Dev Biol. 2019;7:217.
   PubMed Web of Science ®Google Scholar
• Wang P, Xue L, Wang L, et al. Long noncoding RNA DLX6-AS1 promotes migration and invasion of breast cancer cells by upregulating FUS. Panminerva Med. 2020.
   Google Scholar